Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

23.78
+0.56002.41%
Post-market: 24.000.2200+0.93%19:39 EDT
Volume:321.59K
Turnover:7.62M
Market Cap:1.11B
PE:8.88
High:23.89
Open:23.09
Low:23.09
Close:23.22
52wk High:53.96
52wk Low:20.39
Shares:46.50M
Float Shares:35.34M
Volume Ratio:0.74
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.68
EPS(LYR):3.29
ROE:18.32%
ROA:7.31%
PB:1.46
PE(LYR):7.22

Loading ...

Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 18, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 21, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities